Transformation of a low-grade follicular lymphoma into a composite lymphoma combining a high-grade B-cell lymphoma and a lymphoblastic neoplasm expressing Terminal deoxynucleotidyl Transferase: a case report.


Journal

Journal of medical case reports
ISSN: 1752-1947
Titre abrégé: J Med Case Rep
Pays: England
ID NLM: 101293382

Informations de publication

Date de publication:
27 Jul 2020
Historique:
received: 11 11 2019
accepted: 04 06 2020
entrez: 28 7 2020
pubmed: 28 7 2020
medline: 15 5 2021
Statut: epublish

Résumé

High-grade B-cell lymphoma with rearrangements of MYC and BCL2 and/or BCL6 is an aggressive mature B-cell neoplasm, whereas B-lymphoblastic lymphoma is immature cell proliferation, with a frequent positivity for terminal deoxynucleotidyl transferase. The transformation of a low-grade follicular lymphoma into a lymphoblastic neoplasm expressing terminal deoxynucleotidyl transferase is a very rare event. A 55-year-old Caucasian man was followed for a grade 1-2 follicular lymphoma carrying a t(14;18) IGH/BCL2+ and was initially treated with R-CHOP. The follicular lymphoma presented two relapses. In the third relapse, the patient had multiple lymphadenopathy and ascites, which motivated a retroperitoneal biopsy and an ascitic tap. These samples were analyzed by histological, cytological, flow cytometric, cytogenetic, and molecular assessments. The patient died of a multiple organ dysfunction syndrome 2 weeks after his third relapse. The biopsy revealed a diffuse proliferation made up of two types of tumor cells: centroblasts (Bcl-6-positive) and immature cells (terminal deoxynucleotidyl transferase-positive). Flow cytometric analysis confirmed the immature phenotype, with an expression of terminal deoxynucleotidyl transferase, combined with a loss of membrane immunoglobulins. The cytogenetic analysis performed on the ascites revealed a clonal evolution characterized by a t(8;22)(q24;q11) MYC+ translocation not previously detected in follicular lymphoma. Fluorescence in situ hybridization confirmed the double rearrangement of the BCL2 and MYC genes. Polymerase chain reactions and sequencing were used to study the clonal relationship between follicular lymphoma and the secondary tumors. The IGVH gene rearrangement revealed a unique clonal rearrangement involving an IGVH4-59 subset in all three specimens. These findings suggest a clonal relationship between the two types of lymphoma cells. Furthermore, they support the transformation of an acute follicular lymphoma into a composite lymphoma combining a high-grade B-cell lymphoma and a lymphoblastic neoplasm expressing terminal deoxynucleotidyl transferase. This case report highlights the possible transformation of follicular lymphoma into a highly aggressive and immature proliferation.

Sections du résumé

BACKGROUND BACKGROUND
High-grade B-cell lymphoma with rearrangements of MYC and BCL2 and/or BCL6 is an aggressive mature B-cell neoplasm, whereas B-lymphoblastic lymphoma is immature cell proliferation, with a frequent positivity for terminal deoxynucleotidyl transferase. The transformation of a low-grade follicular lymphoma into a lymphoblastic neoplasm expressing terminal deoxynucleotidyl transferase is a very rare event.
CASE PRESENTATION METHODS
A 55-year-old Caucasian man was followed for a grade 1-2 follicular lymphoma carrying a t(14;18) IGH/BCL2+ and was initially treated with R-CHOP. The follicular lymphoma presented two relapses. In the third relapse, the patient had multiple lymphadenopathy and ascites, which motivated a retroperitoneal biopsy and an ascitic tap. These samples were analyzed by histological, cytological, flow cytometric, cytogenetic, and molecular assessments. The patient died of a multiple organ dysfunction syndrome 2 weeks after his third relapse. The biopsy revealed a diffuse proliferation made up of two types of tumor cells: centroblasts (Bcl-6-positive) and immature cells (terminal deoxynucleotidyl transferase-positive). Flow cytometric analysis confirmed the immature phenotype, with an expression of terminal deoxynucleotidyl transferase, combined with a loss of membrane immunoglobulins. The cytogenetic analysis performed on the ascites revealed a clonal evolution characterized by a t(8;22)(q24;q11) MYC+ translocation not previously detected in follicular lymphoma. Fluorescence in situ hybridization confirmed the double rearrangement of the BCL2 and MYC genes. Polymerase chain reactions and sequencing were used to study the clonal relationship between follicular lymphoma and the secondary tumors. The IGVH gene rearrangement revealed a unique clonal rearrangement involving an IGVH4-59 subset in all three specimens.
CONCLUSION CONCLUSIONS
These findings suggest a clonal relationship between the two types of lymphoma cells. Furthermore, they support the transformation of an acute follicular lymphoma into a composite lymphoma combining a high-grade B-cell lymphoma and a lymphoblastic neoplasm expressing terminal deoxynucleotidyl transferase. This case report highlights the possible transformation of follicular lymphoma into a highly aggressive and immature proliferation.

Identifiants

pubmed: 32713346
doi: 10.1186/s13256-020-02433-6
pii: 10.1186/s13256-020-02433-6
pmc: PMC7384216
doi:

Substances chimiques

DNA Nucleotidylexotransferase EC 2.7.7.31

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

117

Références

Case Rep Hematol. 2017;2017:6891957
pubmed: 28884033
Leuk Lymphoma. 2016 Nov;57(11):2626-35
pubmed: 26892631
Am J Clin Pathol. 2015 Sep;144(3):393-410
pubmed: 26276770
Leukemia. 2003 Dec;17(12):2257-317
pubmed: 14671650
Am J Dermatopathol. 2014 Apr;36(4):303-10
pubmed: 23907319
Genes Chromosomes Cancer. 1990 Jul;2(2):147-58
pubmed: 2278969
N Engl J Med. 1988 May 26;318(21):1373-8
pubmed: 3285208
Am J Pathol. 2016 Dec;186(12):3273-3284
pubmed: 27750045
Am J Clin Pathol. 2008 Jan;129(1):157-66
pubmed: 18089500
Leuk Lymphoma. 2011 Nov;52(11):2195-9
pubmed: 21718139
Am J Surg Pathol. 2018 Feb;42(2):269-276
pubmed: 29112016
Am J Pathol. 1999 Jun;154(6):1857-66
pubmed: 10362812
Br J Haematol. 2011 Oct;155(2):274-7
pubmed: 21488860
Am J Clin Pathol. 2004 Apr;121(4):512-25
pubmed: 15080303
CA Cancer J Clin. 2016 Nov 12;66(6):443-459
pubmed: 27618563
Am J Surg Pathol. 2010 Mar;34(3):327-40
pubmed: 20118770
Hum Pathol. 2015 Feb;46(2):260-71
pubmed: 25529125
Int J Clin Exp Pathol. 2015 Aug 01;8(8):9602-8
pubmed: 26464726

Auteurs

Antonin Bouroumeau (A)

Department of Pathology, CHU de Grenoble, Grenoble, France.

Eleonore Kaphan (E)

Department of Hematology, CHU de Grenoble, Grenoble, France.

Clémentine Legrand (C)

Laboratory of Hematology and Oncohematology, CHU de Grenoble, Grenoble, France.

Tatiana Raskovalova (T)

Laboratory of Hematology and Oncohematology, CHU de Grenoble, Grenoble, France.

Gautier Szymanski (G)

Laboratory of Hematology and Oncohematology, CHU de Grenoble, Grenoble, France.

Claire Vettier (C)

Laboratory of Hematology and Oncohematology, CHU de Grenoble, Grenoble, France.

Christine Lefebvre (C)

Laboratory of Hematology and Oncohematology, CHU de Grenoble, Grenoble, France.

Marie-Christine Jacob (MC)

Laboratory of Hematology and Oncohematology, CHU de Grenoble, Grenoble, France.

Anne McLeer (A)

Department of Pathology, CHU de Grenoble, Grenoble, France.

Michel Peuchmaur (M)

Department of Pathology, CHU Robert Debre, Paris, France.

Rémy Gressin (R)

Department of Hematology, CHU de Grenoble, Grenoble, France.

Hervé Sartelet (H)

Department of Pathology, CHU de Grenoble, Grenoble, France. hsartelet@chu-grenoble.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH